168 related articles for article (PubMed ID: 25949789)
1. A reporter mouse for optical imaging of inflammation in mdx muscles.
Martinez L; Ermolova NV; Ishikawa TO; Stout DB; Herschman HR; Spencer MJ
Skelet Muscle; 2015; 5():15. PubMed ID: 25949789
[TBL] [Abstract][Full Text] [Related]
2. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
4. Monitoring disease activity noninvasively in the
Filareto A; Maguire-Nguyen K; Gan Q; Aldanondo G; Machado L; Chamberlain JS; Rando TA
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7741-7746. PubMed ID: 29987034
[TBL] [Abstract][Full Text] [Related]
5. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging to target transplanted muscle progenitor cells.
Gutpell K; McGirr R; Hoffman L
J Vis Exp; 2013 Mar; (73):. PubMed ID: 23568004
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
Gutpell KM; Hrinivich WT; Hoffman LM
PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
[TBL] [Abstract][Full Text] [Related]
8. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
9. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
11. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
12. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
13. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
[TBL] [Abstract][Full Text] [Related]
14. Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy.
McDonald AA; Hebert SL; Kunz MD; Ralles SJ; McLoon LK
Physiol Rep; 2015 Apr; 3(4):. PubMed ID: 25921779
[TBL] [Abstract][Full Text] [Related]
15. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Prostaglandin D Synthase Inhibitor PK007 Decreases Muscle Necrosis in DMD
Yarlagadda S; Kulis C; Noakes PG; Smythe ML
Life (Basel); 2021 Sep; 11(9):. PubMed ID: 34575143
[TBL] [Abstract][Full Text] [Related]
17. In vitro mouse model in Duchenne muscular dystrophy diagnosis using 50-MHz ultrasound waves.
Laux D; Blasco H; Ferrandis JY; Hugon G; Despaux G; Leydier A; Mornet D
Ultrasonics; 2010 Aug; 50(8):741-3. PubMed ID: 20462623
[TBL] [Abstract][Full Text] [Related]
18. Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.
Miglietta D; De Palma C; Sciorati C; Vergani B; Pisa V; Villa A; Ongini E; Clementi E
Orphanet J Rare Dis; 2015 Aug; 10():101. PubMed ID: 26296873
[TBL] [Abstract][Full Text] [Related]
19. Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.
Manning J; Kulbida R; Rai P; Jensen L; Bouma J; Singh SP; O'Malley D; Yilmazer-Hanke D
Exp Physiol; 2014 Oct; 99(10):1370-86. PubMed ID: 24972834
[TBL] [Abstract][Full Text] [Related]
20. Dystrophic pathology in the intrinsic and extrinsic laryngeal muscles in the mdx mouse.
Smythe GM
J Otolaryngol Head Neck Surg; 2009 Jun; 38(3):323-36. PubMed ID: 19476764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
